Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.550
-0.040 (-1.54%)
Jun 23, 2025, 10:44 AM - Market open
Larimar Therapeutics Employees
Larimar Therapeutics had 65 employees as of December 31, 2024. The number of employees increased by 23 or 54.76% compared to the previous year.
Employees
65
Change (1Y)
23
Growth (1Y)
54.76%
Revenue / Employee
n/a
Profits / Employee
-$1,465,092
Market Cap
163.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
LRMR News
- 2 days ago - Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich's Ataxia - GlobeNewsWire
- 7 weeks ago - Larimar Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 5 months ago - Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich's Ataxia - GlobeNewsWire
- 6 months ago - Larimar Therapeutics: Positive Friedreich's Ataxia Data Can Only Get Better - Seeking Alpha
- 6 months ago - What's Going On With Larimar Therapeutics Stock On Tuesday? - Benzinga
- 6 months ago - Why Is Larimar Therapeutics Stock Trading Lower On Monday? - Benzinga